BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Jan 30, 2019

SEC Form 3/A — Form 3/A

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-04-01

Reporting Person: Eddy Jodi Euerle (SVP and CIO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Deferred Stock Units	$	2023-02-15	Common Stock (4616.0000)		Direct
Stock Option (Right to Buy)	$27.0900	2028-02-15	Common Stock (13904.0000)		Direct

Footnotes

F1: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

F2: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.